These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 434066)

  • 1. Lysozyme content of tears in patients with Sjögren's syndrome and rheumatoid arthritis.
    Avisar R; Menaché R; Shaked P; Rubinstein J; Machtey I; Savir H
    Am J Ophthalmol; 1979 Feb; 87(2):148-51. PubMed ID: 434066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysozyme concentration in tears of patients with sicca syndrome.
    Scharf J; Meshulam T; Obedeanu N; Nahir M; Zonis S; Merzbach D
    Ann Ophthalmol; 1982 Nov; 14(11):1063-4. PubMed ID: 7181337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of a homogeneous colorimetric assay for tear lysozyme.
    Klaeger AJ; Cevallos V; Sherman MD; Whitcher JP; Stephens RS
    Ocul Immunol Inflamm; 1999 Mar; 7(1):7-15. PubMed ID: 10410870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of bromhexine on Sjögren's syndrome accompanied by rheumatoid arthritis.
    Kawashima K
    Nihon Ika Daigaku Zasshi; 1988 Apr; 55(2):191-200. PubMed ID: 3392169
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitation of tear lysozyme levels in dry-eye disorders.
    deLuise VP; Tabbara KF
    Arch Ophthalmol; 1983 Apr; 101(4):634-5. PubMed ID: 6838425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tear lysozyme in the sicca syndrome (author's transl)].
    Ueda T; Sugita Y; Kitano S
    Nippon Ganka Gakkai Zasshi; 1979 Sep; 83(9):1509-16. PubMed ID: 525580
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of bromhexine on tear lysozome level in keratoconjunctivitis sicca.
    Scharf JM; Obedeanu N; Meshulam T; Nahir M; Merzbach D; Scharf JA; Zonis S
    Am J Ophthalmol; 1981 Jul; 92(1):21-3. PubMed ID: 7258276
    [No Abstract]   [Full Text] [Related]  

  • 8. [Quantitative determination of lysozyme in tears and diagnosis of dry eye].
    Rong BL
    Zhonghua Yan Ke Za Zhi; 1984 Jul; 20(4):228-31. PubMed ID: 6439523
    [No Abstract]   [Full Text] [Related]  

  • 9. Alternate-day steroid therapy for patients with primary Sjögren's syndrome.
    Tabbara KF; Frayha RA
    Ann Ophthalmol; 1983 Apr; 15(4):358-61. PubMed ID: 6660708
    [No Abstract]   [Full Text] [Related]  

  • 10. Lysozyme determination in parotid saliva from patients with Sjögren's syndrome.
    Moutsopoulos HM; Karsh J; Wolf RO; Tarpley TM; Tylenda A; Papadopoulos NM
    Am J Med; 1980 Jul; 69(1):39-42. PubMed ID: 7386505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tear lipocalin and lysozyme in Sjögren and non-Sjögren dry eye.
    Caffery B; Joyce E; Boone A; Slomovic A; Simpson T; Jones L; Senchyna M
    Optom Vis Sci; 2008 Aug; 85(8):661-7. PubMed ID: 18677232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imbalanced Rab3D versus Rab27 increases cathepsin S secretion from lacrimal acini in a mouse model of Sjögren's Syndrome.
    Meng Z; Edman MC; Hsueh PY; Chen CY; Klinngam W; Tolmachova T; Okamoto CT; Hamm-Alvarez SF
    Am J Physiol Cell Physiol; 2016 Jun; 310(11):C942-54. PubMed ID: 27076615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tear fluid plasmin activity of dry eye patients with Sjögren's syndrome.
    Virtanen T; Konttinen YT; Honkanen N; Härkönen M; Tervo T
    Acta Ophthalmol Scand; 1997 Apr; 75(2):137-41. PubMed ID: 9197558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sjögren's syndrome and tear function parameters.
    van Bijsterveld OP; Mackor AJ
    Clin Exp Rheumatol; 1989; 7(2):151-4. PubMed ID: 2736827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The normal tear fluid and decreased tearing in patients with Sjögren's disease and Sjögren's syndrome. I. The protein and glucose content].
    Morozova RP; Zhaboiedov HD; Kirieiev VV; Nikolenko IA
    Ukr Biokhim Zh (1978); 1996; 68(2):77-82. PubMed ID: 9005667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tear fluid analysis in primary Sjögren's syndrome.
    Markusse HM; van Haeringen NJ; Swaak AJ; Hogeweg M; de Jong PT
    Clin Exp Rheumatol; 1993; 11(2):175-8. PubMed ID: 7685257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between impression cytology and tear function parameters in Sjögren's syndrome.
    Rivas L; Rodriguez JJ; Alvarez MI; Oroza MA; del Castillo JM
    Acta Ophthalmol (Copenh); 1993 Jun; 71(3):353-9. PubMed ID: 7689780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tear lysozyme activity in frozen Schirmer strips and salivary gland biopsy as parameters of lacrimal gland function.
    Klaeger AJ; Whitcher JP; Daniels TE
    Ocul Immunol Inflamm; 1999 Mar; 7(1):3-6. PubMed ID: 10410869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lacrimal immunoglobulins in rheumatoid arthritis patients with or without Sjögren's syndrome.
    Domingo I; Coll J; Ribas-Montobio J; Marrugat J; Rubiés-Prat J
    Ophthalmologica; 1998; 212(1):30-3. PubMed ID: 9438581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical reduced G6PD activity in rheumatoid arthritis and Sjögren's Syndrome patients: relation to clinical characteristics, disease activity and metabolic syndrome.
    Gheita TA; Kenawy SA; El Sisi RW; Gheita HA; Khalil H
    Mod Rheumatol; 2014 Jul; 24(4):612-7. PubMed ID: 24252052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.